Vanguard Group’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-31,308
| Closed | -$110K | – | 4142 |
|
|
2018
Q1 | $110K | Sell |
31,308
-2,428
| -7% | -$8.53K | ﹤0.01% | 4023 |
|
|
2017
Q4 | $105K | Buy |
33,736
+3,572
| +12% | +$11.1K | ﹤0.01% | 3989 |
|
|
2017
Q3 | $212K | Sell |
30,164
-314
| -1% | -$2.21K | ﹤0.01% | 3907 |
|
|
2017
Q2 | $281K | Buy |
+30,478
| New | +$281K | ﹤0.01% | 3840 |
|
|
2017
Q1 | – | Sell |
-24,780
| Closed | -$208K | – | 4073 |
|
|
2016
Q4 | $208K | Buy |
+24,780
| New | +$208K | ﹤0.01% | 3882 |
|